Please login to order a test.
- JAK2 V617F (Exon 14 Mutation)
- Janus Kinase 2V617F Mutation Detection
The JAK2V617F (exon 14) mutation analysis can be used in conjunction with bone marrow histology and cytogenetic analysis to assist in the diagnosis of myeloproliferative neoplasms (MPN). The JAK2V617F mutation is found in almost all patients with polycythemia vera (PV) and in nearly one- half of those with idiopathic myelofibrosis (IMF) and with essential thrombocythemia (ET). The V617F mutation has also been detected, although infrequently, in other myeloid disorders, such as chronic myelomonocytic leukemia and chronic neutrophilic leukemia.
This analysis will only detect the nucleotide change encoding the V617F mutation within JAK2. Other mutations within the JAK2 gene will not be detected by this analysis. This assay has a sensitivity of approximately 5% for the detection of cells containing the JAK2 mutation within a background of nonmutant cells. A negative result does not exclude the presence of a chronic myeloproliferative disorder or other neoplastic process.
Allele-specific polymerase chain reaction (PCR); capillary electrophoresis
Whole blood or bone marrow
3 to 5 mL whole blood or 1 to 2 mL bone marrow
3 mL whole blood or 1 mL bone marrow
Causes for Rejection
Sample greater than 72 hours old; clotted blood
Please direct any questions regarding this test to customer service at 800-345-4363.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|489200||JAK2 Mutation Analysis, Qual||489201||JAK2 V617F mutation detection||43399-5|
|489200||JAK2 Mutation Analysis, Qual||489204||Director Review:||72486-4|
|489200||JAK2 Mutation Analysis, Qual||489347||Background:||77202-0|
|489200||JAK2 Mutation Analysis, Qual||489457||JAK2 Mutation Analysis, Qual||N/A|